The Netherlands Compounding Pharmacies Market Growth Accelerated by Rising Demand for Personalized Medications


Compounding pharmacies combine, mix, or alter ingredients to create customized medications to meet individual patient needs based on their unique medical conditions. Compounding pharmacies help patients who may not be able to tolerate pre-filled prescription drugs or require specialized formulations not available commercially.

The Netherlands Compounding Pharmacies Market is estimated to be valued at US$ 599.62 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing demand for personalized medications is one of the key factors driving the growth of the Netherlands Compounding Pharmacies Market. Compounded medications provide an alternative for patients who require customized dosage forms, flavors, or ingredients unavailable in commercially available prescription drugs. Compounding pharmacies help overcome shortages, improve tolerability, and optimize therapeutic outcomes. They are able to compound specialized medicines tailored to the needs of individual patients, thereby accelerating the demand for personalized medications.


Segment Analysis
The Netherlands compounding pharmacies market size is dominated by the hospital and clinic pharmacy segment. This is because compounding pharmacies are usually based in hospitals and clinics to be able to cater to customized medication needs of inpatients. Compounding pharmacies also serve long-term care facilities and individual patients in the Netherlands. However, the hospital and clinic pharmacy segment accounts for the largest share as these are continually serving the needs of inpatients and emergency cases in hospitals and clinics on a daily basis.

Key Takeaways

The Netherlands compounding pharmacies market is expected to witness high growth over the forecast period of 2024 to 2031. The market is expected to reach a value of US$ 599.62 Mn by 2024 and expand at a CAGR of 6.5% from 2024 to 2031.

Regional analysis: The Netherlands compounding pharmacies market is dominated by Western Europe. This can be attributed to rising aging population suffering from chronic diseases in Western European countries like Netherlands, Germany and France. According to estimates around 20% of total Netherlands population is aged 65 years and above. The demand for compounded medications is high in Western Europe as compounded medications are help cater to geriatric medical needs in a customized way.

Key players: Key players operating in the Netherlands compounding pharmacies market include GE Healthcare,,Invacare Corporation,,IUC Medical (Smiths Medical),,HERSILL S.L.,,Fisher & Paykel Healthcare Limited,,Philips Respironics, Inc.,,DeVilbiss Healthcare,,Tecno-Gaz Industries,,Allied Healthcare Products, Inc.,,Teleflex Incorporated,,Chart Industries,,ResMedDrägerwerk AG & Co. KGaALinde,,CAIRE. GE Healthcare, and Invacare Corporation are currently dominating the Netherlands compounding pharmacies market owing to their strong distribution network and brand presence across Netherlands.

Comments

Popular posts from this blog

The global Ion Exchange Membrane Market Growth Accelerated by Increasing Industrialization and Urbanization

Healthcare IT (HCIT) is fastest growing segment fueling the growth of Drug for Abuse Testing Devices Market

Electric Powertrain Market Growth Accelerated by Adoption of Stringent Emission Regulations